ATRenew Stock (NYSE:RERE), Trade Ideas

ATRenew

ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.

AiHuiShou Intl

Penny Stocks

Small Cap

Markets

Tech

AAPL

RERE

&#39;Perfect Storm&#39; Of Factors Fuels Rise In Smartphone Recycling

Asia

CVNA

REAL

RENT

Key Takeaways:


	ATRenew’s revenue rose 30% in the fourth quarter, as its non-GAAP operating margin improved by 0.9 percentage points on growing efficiencies
	The company’s iPhone recycling collaboration with Apple generated an additional 300 million yuan in revenue during the fourth quarter


By Doug Young

ATRenew Polishes Recycling Credentials To Record First Profit

News

Intraday Update

Movers

Trading Ideas

BNAI

GOOG

GOOGL

NVDA

NVEI

NYXH

QBTS

QRTEB

SHCO

SWIM

TLRY

XPEV

U.S. stocks were higher, with the Dow Jones index gaining around 100 points on Monday.

Alphabet, Nvidia, PepsiCo And Other Big Stocks Moving Higher On Monday

ATRenew Inc. American Depositary Shares (every three of which representing two Class A ordinary shares)

ATRenew Inc

As 4/20 is upons us, <a href="https://www.benzinga.com/topic/weedmaps">Weedmaps </a>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAPS#NASDAQ">MAPS</a>) has provided valuable insights to forecast a significant sales boost for the industry and a widespread celebration of marijuana. The data, derived from big data analysis of user activities on the platform, indicates that the previous year&#8217;s 4/20 was highly successful, with Weedmaps experiencing a twofold increase in normal operations.
<h2 class="wp-block-heading">Big Data, Big Deals</h2>
Weedmaps pointed out that consumers are prioritizing value, as the platform registered a 200% surge in orders that redeem deals through the platform during 4/20 week of 2023 compared to 2022.&nbsp;
Furthermore, the platform has observed a rising trend in usage, with deal claims increasing by 100% over 2022. This uptick is likely motivated by price reductions, as the costs for flowers, vape pens, and edibles have continued to decrease for the second consecutive year, showing declines of 15%, 14%, and 17% when compared to 2021.
Weemaps also shared that consumers will probably be expending even more in goods than years before, since the average order value surged to $96.22 in 2023, a 14% increase compared to an average Thursday in April of 2023. This is despite deflation.
Additionally, the quantity of orders expanded by an average of 25% in terms of items per basket on 4/20 of last year, in comparison to 2022.
<h2 class="wp-block-heading">Category Insights</h2>
<ul>
<li>During the 4/20 retail week of 2023, vape pens witnessed a 29% growth over 2022, and an impressive 126% increase compared to 2020, with the largest demographic being Gen Z (31%).</li>
</ul>
<ul>
<li>Edibles are predominantly favored by consumers aged 50 and above, accounting for nearly half of all edible sales. The edibles category saw a 36% rise in orders during the 4/20 week of 2023 compared to the previous year.</li>
</ul>
<ul>
<li>Cannabis flower remains the top choice across all age groups, with nearly half of all orders on 4/20 in 2023 falling into this category. Remarkably, sales of flowers through Weedmaps surged by 47% on 4/20 compared to the prior year, and this growth expanded to 202% when compared to 4/20 in 2020.</li>
</ul>

Cannabis

MAPS

Unparalleled 4/20: Weedmaps Unveils Consumer Trends Ahead Of Cannabis Industry's Biggest Holiday

As you may have heard, cannabis consumption among older folks is on the rise. More specifically, seniors are one of the fastest-growing groups of <a href="https://www.benzinga.com/cannabis">cannabis users in the U.S. </a>
As it turns out, many older adults have been consuming weed for decades and new ones are joining in on the fun. Cannabis consumption among our parents and grandparents has quadrupled in the past eight years.
Study after study suggests that older adults are using cannabis to remedy an array of conditions such as sleep issues, pain,&nbsp;inflammation and to activate their appetites. 
But most consume because they still enjoy getting high.
"Sure, I sleep better with cannabis and topical creams alleviate my knee pain, but that's all new. I've been smoking pot for the past four decades and I see no reason to stop getting high," said Cynthia P who recently retired as an ER nurse in Ohio where recreational marijuana <a href="https://www.benzinga.com/markets/cannabis/23/11/35664155/ohio-legalizes-cannabis-and-overwhelmingly-approves-abortion-rights">became legal</a> last November.
Scientists and researchers are wisely becoming interested in this Baby Boomer demographic of 77 million, many of whom are healthy, economically stable and have no plans of checking out anytime soon, so they say.
One particular<a href="https://www.frontiersin.org/articles/10.3389/fnagi.2022.804890/full" target="_blank" rel="noreferrer noopener">&nbsp;study</a>,&nbsp;that examined marijuana use in adults aged&nbsp;60 to 88 found that&nbsp;whole-plant cannabis did&nbsp;not harm&nbsp;cognition but rather the opposite.&nbsp;Older cannabis users, relative to non-users, had&nbsp;significantly greater neuronal communication between the cerebellum and hippocampus.
Why? Age-related changes in the&nbsp;<a href="https://www.benzinga.com/markets/cannabis/22/07/28272841/the-endocannabinoid-system-101-the-basics-made-easy" target="_blank" rel="noreferrer noopener">endocannabinoid system</a>&nbsp;(ECS) include a decrease in the number of cannabinoid receptors throughout the brain.&nbsp;The ECS,&nbsp;a significant aspect of our human physiology that&nbsp;helps maintain homeostasis,&nbsp;is a complex cell-signaling system in the brain and body that interacts with just about all of our&nbsp;other body systems.&nbsp;
Which means? During normal aging, the decline in cannabinoid receptors correlates with increased levels of inflammation in these brain regions causing a loss of neurons in the hippocampus, which is critical for learning and&nbsp;memory.&nbsp;This, in short, explains age-related memory impairment.&nbsp;&nbsp;
"Oh, I believe that," Cynthia told Benzinga. "While I never consumed for a full shift before going to work, I'm convinced that marijuana has helped keep me and my mind sharp as I aged. I'm not saying it's for everyone, but for people of my generation there's nothing better."
Now Read: <a href="https://www.benzinga.com/markets/cannabis/24/04/38341776/hemp-space-grew-3x-the-rate-of-cannabis-where-did-marijuana-get-it-wrong">Hemp Space Grew 3X The Rate Of Cannabis, Where Did Marijuana Get It Wrong?</a>
Photo: Shutterstock

Exclusives

It's 4/20, Do You Know Where Your Parents Are?

The Detroit Lions finished with one of their best records in years for the 2023 season, which means they will have a lower pick in the<a href="https://www.benzinga.com/nfldraft/"> 2024 NFL Draft.</a>
Would General Manager Brad Holmes consider trading out of the first round with the 2024 NFL Draft taking place in Detroit?
What Happened: Detroit Lions fans might not like the answer given by Holmes to the media on scenarios that could see the Lions trade their 29th overall first-round pick and move back in the <a href="https://www.benzinga.com/nfldraft/detroit-live-events/">2024 NFL Draft.</a>
Holmes was asked about a scenario of trading out of the first round and didn't hesitate to say he will do what is best for the franchise.
"We have to do the right thing for the organization," Holmes said, as <a href="https://www.detroitlions.com/news/holmes-prepared-to-apologize-to-fans-if-lions-trade-out-of-first-round">reported </a>by Lions writer Mike O'Hara.
Holmes said while he would consider trading out of the first round, it's important to note that, with the draft taking place in Detroit, there might be a greater chance of upsetting the fans if he makes such a move.
A trade out of the first round could mean that any Lions fans in attendance Thursday will have spent all day downtown to watch other teams take their players in the draft.
Holmes said he would send out a "PSA and apologize" if he trades out of the first round.
"Hopefully, our fans will forgive us. We won't expect immediate forgiveness right then and there, but hopefully when the season starts."
Detroit was announced as the host city for the NFL Draft back in 2022.
"Another opportunity for our franchise and our city and just for the world to kind of migrate to downtown Detroit," Holmes said earlier this week.
Related Link: <a href="https://www.benzinga.com/general/sports-betting/24/04/38318190/michigan-wolverines-will-have-6-high-demand-players-in-2024-nfl-draft-will-history-repeat-">Michigan Wolverines Will Have 6 High-Demand Players In 2024 NFL Draft: Will History Repeat Itself?</a>
Why It's Important: Holmes is no stranger to trading in the NFL Draft. Since joining as the Lions GM in 2021, Holmes has taken part in several drafts for the team and is known for dealmaking.
This includes the 2023 NFL Draft, which saw the Lions trade their sixth overall pick, acquired from the Los Angeles Rams in the Matthew Stafford trade. The Lions traded the sixth pick to the Arizona Cardinals and received back the 12th, 34th and 168th overall picks.
Lions fans will remember the 2023 Draft saw several impact players taken including running back Jahymyr Gibbs with the 12th pick and tight end Sam LaPorta with the 34th pick. Both rookies played in the 2023 NFL season and were among the top first-year players, finishing third and fourth, respectively, in NFC offensive rookie of the year voting.
The 12-5 record and appearance in the NFC Championship game gives the Lions the 29th overall pick, one of their lowest earned in years.
The Lions also have the 61st overall pick and 73rd, but have only those three picks in the first four rounds, with no fourth-round pick this year. This could prompt Holmes to be open to trades to pick up additional picks. The Lions also have a fifth-round pick, two sixth-round picks and a seventh-round pick, for seven overall picks.
In the 2023 NFL Draft, the Lions had eight picks, including two first-round picks and two second-round picks.
The Lions have had a first round pick in every season since 1994, with 1993 being the last year they didn't select a player in the first round.
The Lions&#8217; top needs by position include cornerback, offensive line and wide receiver. The Lions last took a wide receiver in the first round of 2022 (Jameson Williams) and a cornerback in the first round of 2020 (Jeff Okudah). For the offensive line, the Lions last took a guard or center in the first round in 2018 with Frank Ragnow, and last took an offensive tackle in the first round in 2021 with Penei Sewell. Of these four players, three are still with the Lions.
Join Benzinga's live draft reaction show Thursday, April 25 to hear our instant thought on who the Lions take 29th overall or our reaction to the Lions trading out of the first round.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="&#x1f534; LIVE NFL Draft Watch Party: Benzinga&#039;s Expert Analysis &amp; Reactions!" width="500" height="281" src="https://www.youtube.com/embed/XMBqIWZb7h0?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Photo via Shutterstock.

Sports

Detroit Lions Have First-Round Pick Every Year Since 1994: Would They Really Trade Out With Draft In Motor City?

&quot;We are disappointed to announce the wind-down of our Phase 2 NASH trial, which we attribute entirely to resource constraints,&quot; said John Brancaccio, Executive Chairman of Hepion. &quot;The Company remains committed to its strategic alternative efforts previously announced in December 2023. Given the number of enrolled NASH patients to date and the low probability of generating relevant efficacy data to support a registrational trial with our current cash resources, we have opted to wind down the program and assure that patients are transitioned out of the trial in a safe and compliant manner. There were no safety concerns observed for rencofilstat in the ASCEND-NASH trial.&quot;

Biotech

General

HEPA

Hepion Pharmaceuticals Says Given The Number Of Enrolled NASH Patients To Date And The Low Probability Of Generating Relevant Efficacy Data To Support A Registrational Trial With Our Current Cash Resources, We Have Opted To Wind Down The Program And Assure That Patients Are Transitioned Out Of The Trial In A Safe And Compliant Manner"

Hepion Pharmaceuticals Shares Resumed Trading

Sen. Elizabeth Warren (D-Mass.) voiced her support for a Department of Justice antitrust case against leading technology company Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), which was <a href="https://www.benzinga.com/news/24/03/37905532/apple-slams-dangerous-doj-lawsuit-tim-cooks-iphone-suggestion-returns-to-haunt-and-potential-google">announced last month.</a>
In comments shared on social media, Warren took aim at the smartphone market segment of Apple.
What Happened: Apple is one of the largest smartphone companies in the world and in 2023 had seven of the top 10 selling smartphones globally <a href="https://www.benzinga.com/news/24/02/37245799/apple-dominates-2023-smartphone-list-with-7-of-top-10-models-why-its-important-for-iphone-growth">according to a report.</a>
According to Warren, Apple has a monopoly in the smartphone market and one of the company's key features could be ruining friendships and relationships.
"Green texts on iPhones, they're ruining relationships," Warren <a href="https://twitter.com/SenWarren/status/1781086997014040759">said </a>in a video posted on X.
The green texts refer to the texts that come from non-Apple phones in green bubbles versus the blue bubbles displayed by iPhone users.
"Non iPhone users everywhere are being excluded from group texts."
Warren said that this means some non-Apple smartphone users are not being included in chats about vacation plans, group chats or chats with other sports fans.
"And who's to blame here? Apple."
Warren said that the green vs. blue bubble text icons are just one example of the dirty tactics used by Apple to "keep a stranglehold on the smartphone market."
"Apple has used its monopoly on the smartphone to lock Americans into services and amass billions of dollars in profits."
Warren mentioned that apps that would let Google users use iMessage and get blue texts were <a href="https://www.benzinga.com/news/23/12/36165068/apple-pulls-plug-on-imessage-for-android-app-beeper-mini-its-back-to-green-bubbles-now-for-android-u">blocked by Apple.</a>
"It's time to break up Apple's monopoly now."
Related Link: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37876155/apple-doj-lawsuit-could-challenge-core-business-model-leading-analyst-predicts-what">Apple DOJ Lawsuit Could Challenge &#8216;Core Business Model&#8217;: Leading Analyst Predicts What&#8217;s Next For Tech Giant</a>
Why It's Important: The video shared by Warren was Community Noted on X, with readers providing more context.
"As of Jan 2024, iPhone has a 57% market share, to Android 42% in North America. A monopoly is exclusive control, or no close substitutes," the note reads.
In March, the Department of Justice filed an antitrust suit against Apple, which includes allegations that the company restricts access to iPhone hardware and software features.
A <a href="https://9to5mac.com/2024/04/19/elizabeth-warren-on-green-texts/">report </a>from 9to5Mac indicates that the antitrust lawsuit now encompasses claims from non-iPhone users who feel socially stigmatized and excluded in chats with iPhone users. This issue stems from the ongoing<a href="https://www.benzinga.com/news/23/09/34818276/get-the-message-google-roasts-apple-with-new-mocking-ipager-add-to-end-green-vs-blue-text-bubbles-wa"> blue vs. green bubble text debate.</a>
AAPL Price Action: Apple shares closed at $165.00 on Friday, versus a 52-week trading range of $162.80 to $199.62.
Read Next:<a href="https://www.benzinga.com/general/politics/24/04/38305131/elizabeth-warren-says-trump-had-only-2-accomplishments-as-president-huge-difference-between-bide"> Elizabeth Warren Says Trump Had Only 2 Accomplishments As President: &#8216;Huge Difference Between&#8217; Biden, Trump</a>
Photo: Shutterstock

Politics

Legal

Elizabeth Warren Attacks Apple Smartphone 'Monopoly': 'Green Texts On iPhones, They're Ruining Relationships'

Trading Halt: Halt status updated at 4:55:00 PM ET: Quotation Resumption: News and Resumption Times

Management

AFJK

On April 15, Aimei Health Technology's Juan Fernandez Pascual Tendered His Resignation As CEO, Secretary And A Director; Co Appointed Junheng Xie As CEO, Secretary And A Director

Global

Honda Exec Says Company To Invest 4.2B Reais In Brazil Plant, Focusing On Hybrid-Flex Vehicles

COSM

Cosmos Health Received Nasdaq Notice On Late Filing Of Its Form 10-K; On April 17 Received Notification Letter Stating Co Is No Longer In Compliance With Nasdaq Listing Rule 5250(c)(1); Intends To Resolve Deficiency And Regain Compliance With Nasdaq Listing Rules

BTOG

On Feb 19, Bit Origin Ltd Terminated Employment Of Its CFO, Xia Wang; On April 10, Lucas Wang Resigned As CEO And Chairman Of Board; Current COO, Has Been Appointed CEO, Chairman Of Board And A Director Of Co; Co To Conduct A Search To Replace Xia Wang As Company's CFO

Whales with a lot of money to spend have taken a noticeably bearish stance on ServiceNow.
Looking at options history for ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) we detected 56 trades.
If we consider the specifics of each trade, it is accurate to state that 35% of the investors opened trades with bullish expectations and 64% with bearish.
From the overall spotted trades, 25 are puts, for a total amount of $1,473,153 and 31, calls, for a total amount of $2,469,435.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $300.0 to $1040.0 for ServiceNow over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for ServiceNow's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of ServiceNow's whale trades within a strike price range from $300.0 to $1040.0 in the last 30 days. 
<h3>ServiceNow Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713559550_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$108.8</td>
<td>$106.7</td>
<td>$108.8</td>
<td>$700.00</td>
<td>$598.4K</td>
<td style="text-align: right;">142</td>
<td style="text-align: right;">56</td>
</tr>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$37.0</td>
<td>$31.7</td>
<td>$36.5</td>
<td>$500.00</td>
<td>$310.2K</td>
<td style="text-align: right;">35</td>
<td style="text-align: right;">85</td>
</tr>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/10/24</td>
<td>$39.1</td>
<td>$36.7</td>
<td>$39.1</td>
<td>$700.00</td>
<td>$293.2K</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">75</td>
</tr>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$32.8</td>
<td>$32.1</td>
<td>$32.1</td>
<td>$720.00</td>
<td>$227.9K</td>
<td style="text-align: right;">75</td>
<td style="text-align: right;">2</td>
</tr>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$33.0</td>
<td>$31.9</td>
<td>$33.0</td>
<td>$800.00</td>
<td>$132.0K</td>
<td style="text-align: right;">131</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>

<h3>About ServiceNow</h3>
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.
<h3>Current Position of ServiceNow</h3>
<ul>
<li>Trading volume stands at 1,536,830, with NOW's price down by -2.39%, positioned at $713.91.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 5 days.</li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for ServiceNow, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

This Is What Whales Are Betting On ServiceNow

Financial giants have made a conspicuous bearish move on AstraZeneca. Our analysis of options history for AstraZeneca (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>) revealed 12 unusual trades.
Delving into the details, we found 16% of traders were bullish, while 83% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $90,336, and 9 were calls, valued at $981,928.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $66.0 and $77.5 for AstraZeneca, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for AstraZeneca's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AstraZeneca's whale activity within a strike price range from $66.0 to $77.5 in the last 30 days. 
<h3>AstraZeneca Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713559545_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AZN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/19/24</td>
<td>$1.06</td>
<td>$0.9</td>
<td>$0.9</td>
<td>$67.50</td>
<td>$594.6K</td>
<td>14.1K</td>
<td>8.2K</td>
</tr>
<tr>
<td>AZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/19/24</td>
<td>$1.65</td>
<td>$1.54</td>
<td>$1.55</td>
<td>$67.00</td>
<td>$69.4K</td>
<td>2.5K</td>
<td>2.3K</td>
</tr>
<tr>
<td>AZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/19/24</td>
<td>$1.52</td>
<td>$1.51</td>
<td>$1.51</td>
<td>$67.00</td>
<td>$67.6K</td>
<td>2.5K</td>
<td>1.0K</td>
</tr>
<tr>
<td>AZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/19/24</td>
<td>$1.49</td>
<td>$1.25</td>
<td>$1.49</td>
<td>$67.00</td>
<td>$66.7K</td>
<td>2.5K</td>
<td>24</td>
</tr>
<tr>
<td>AZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/19/24</td>
<td>$1.57</td>
<td>$1.48</td>
<td>$1.49</td>
<td>$67.00</td>
<td>$49.6K</td>
<td>2.5K</td>
<td>920</td>
</tr>
</tbody>
</table>

<h3>About AstraZeneca</h3>
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.
Following our analysis of the options activities associated with AstraZeneca, we pivot to a closer look at the company's own performance.
<h3>Where Is AstraZeneca Standing Right Now?</h3>
<ul>
<li>With a trading volume of 4,720,283, the price of AZN is up by 0.28%, reaching $68.55.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 6 days from now.</li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest AstraZeneca options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Looking At AstraZeneca's Recent Unusual Options Activity

Investors with a lot of money to spend have taken a bearish stance on Astera Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ALAB, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 9 options trades for Astera Labs.
This isn't normal.
The overall sentiment of these big-money traders is split between 44% bullish and 55%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $55,500, and 8, calls, for a total amount of $413,781.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $35.0 to $100.0 for Astera Labs during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Astera Labs's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Astera Labs's whale trades within a strike price range from $35.0 to $100.0 in the last 30 days. 
<h3>Astera Labs Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713559539_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$21.0</td>
<td>$20.0</td>
<td>$21.0</td>
<td>$50.00</td>
<td>$73.5K</td>
<td style="text-align: right;">43</td>
<td style="text-align: right;">39</td>
</tr>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$32.7</td>
<td>$30.9</td>
<td>$32.52</td>
<td>$35.00</td>
<td>$65.0K</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
</tr>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$7.7</td>
<td>$7.6</td>
<td>$7.6</td>
<td>$65.00</td>
<td>$63.8K</td>
<td style="text-align: right;">37</td>
<td style="text-align: right;">89</td>
</tr>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$6.1</td>
<td>$5.6</td>
<td>$5.9</td>
<td>$65.00</td>
<td>$59.0K</td>
<td style="text-align: right;">37</td>
<td style="text-align: right;">472</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/19/24</td>
<td>$11.1</td>
<td>$10.7</td>
<td>$11.1</td>
<td>$75.00</td>
<td>$55.5K</td>
<td style="text-align: right;">425</td>
<td style="text-align: right;">66</td>
</tr>
</tbody>
</table>

<h3>About Astera Labs</h3>
Astera Labs Inc is a company that offers an Intelligent Connectivity Platform, comprised of Semiconductor-based, high-speed mixed-signal connectivity products that integrate a matrix of microcontrollers and sensors. COSMOS, their software suite which is embedded in its connectivity products and integrated into their customers' systems. The Company delivers critical connectivity performance, enables flexibility and customization, and supports observability and predictive analytics. This approach addresses the data, network, and memory bottlenecks, scalability, and other infrastructure requirements of hyperscalers and system original equipment manufacturers.
Having examined the options trading patterns of Astera Labs, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Astera Labs</h3>
<ul>
<li>Trading volume stands at 3,996,863, with ALAB's price down by -10.18%, positioned at $63.7.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 14 days.</li>
</ul>
<h3>What Analysts Are Saying About Astera Labs</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $88.0.
<ul>
<li>Reflecting concerns, an analyst from Evercore ISI Group lowers its rating to Outperform with a new price target of $100.</li>
<li>An analyst from Barclays downgraded its action to Overweight with a price target of $85. </li>
<li>Reflecting concerns, an analyst from Roth MKM lowers its rating to Buy with a new price target of $85.</li>
<li>In a cautious move, an analyst from JP Morgan downgraded its rating to Overweight, setting a price target of $85. </li>
<li>Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $85.</li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Astera Labs, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

ALAB

Decoding Astera Labs's Options Activity: What's the Big Picture?

GILD

LPTX

Leap Therapeutics 13G Filing Shows Gilead Sciences, Inc. Reported A 13.9% Stake In The Co As Of April 10, 2024

Offerings

KZIA

Kazia Therapeutics Ltd Entered Into Purchase Agreement With Alumni Capital LP; Pursuant To Purchase Agreement, May Sell To Alumni Capital Up To $15M Of American Depositary Shares From Time To Time

MNTS

Momentus Inc Receives Nasdaq Deficiency Notification Regarding Delayed Form 10-K

Gulf Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GURE#NASDAQ">GURE</a>) ("Gulf Resources" or the "Company"), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that it received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that due to the Company's failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the "2023 Form 10-K"), with the Securities and Exchange Commission (the "SEC"), the Company is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the "Rule"), which requires the timely filing of all required periodic reports with the SEC. &nbsp;
The Notice has no immediate effect on the listing of the Company's common stock on Nasdaq. Under the Nasdaq rules, the Company has 60 calendar days, or until June 17, 2024, to file the 2023 Form 10-K or to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rule. If the Company submits a plan to Nasdaq and Nasdaq accepts the plan, Nasdaq can grant an exception of up to 180 calendar days from the filing's due date, or until October 14, 2024, to regain compliance. If the Company fails to timely regain compliance with Nasdaq Listing Rule 5250(c)(1), the Company's common stock will be subject to delisting from Nasdaq.
The Company continues to work diligently to complete the 2023 Form 10-K and currently intends to file the 2023 Form 10-K by no later than June 10, 2024.
This announcement is made in compliance with the Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a notification of deficiency.

GURE

Gulf Resources Announces Receipt Of Nasdaq Non-Compliance Notice Notifying The Company That Due To The Co's Failure To Timely File Its Annual Report On Form 10-K For The Fiscal Year Ended December 31, 2023

Lifecore Biomedical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFCR#NASDAQ">LFCR</a>) (the "Company") announced today that, on April 15, 2024, the Company received a notification letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of the Company's delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended February 25, 2024 (the "Q3 Form 10-Q") and its continued delay in filing its Quarterly Report on Form 10-Q for the quarterly periods ended August 27, 2023 and November 29, 2023 (the "Q1 Form 10-Q" and "Q2 Form 10-Q," respectively, and together with the Q3 Form 10-Q, the "Filings") with the Securities and Exchange Commission (the "SEC"), the Company continues not to be in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), and that the Nasdaq Hearings Panel would consider the delinquency in the filing of the Q3 Form 10-Q in rendering its determination regarding the Company's continued listing on Nasdaq Global Select Market. &nbsp;
The Notice has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Global Select Market. As previously disclosed, Nasdaq had previously granted the Company until February 12, 2024 to regain compliance with the Listing Rule, and, on February 13, 2024, the Company received the Staff Delisting Determination notifying the Company that Nasdaq has initiated a process which could result in the delisting of the Company's securities from Nasdaq as a result of the Company not being in compliance with the Listing Rule. The Company appealed the Staff Delisting Determination, and, on April 16, 2024, the Company appeared for the hearing in which the Company requested a further stay of any suspension or delisting action to enable the Company to regain compliance with the Listing Rule. The Nasdaq Hearings Panel has not yet issued its decision, although the Company anticipates that a decision will be forthcoming.
The Company continues to work diligently to complete the Filings and intends to file the Filings as promptly as possible to regain compliance under the Listing Rule. However, there can be no assurance that such periodic reports will be filed before the expiration of any stay granted by Nasdaq, or that the Nasdaq Hearing Panel will grant the Company's request for a further stay of any suspension or delisting action
This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.

LFCR

Lifecore Biomedical, Inc. Receives Notice From Nasdaq Regarding Delayed Quarterly Report For The Fiscal Quarter Ended February 25, 2024 And Its Continued Delay In Filing Its Quarterly Report On Form 10-Q For The Quarterly Periods Ended August 27, 2023 And November 29, 2023

Odyssey Marine Exploration, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMEX#NASDAQ">OMEX</a>), a global subsea mineral exploration and validation company, reported that on April 17, 2024, Odyssey received a notice from Nasdaq Regulation that Odyssey is not in compliance with Nasdaq Rule 5250(c)(1) because it had not yet filed its Form 10-K for the period ended December 31, 2023 (the "Form 10-K") with the Securities and Exchange Commission (SEC). Odyssey plans to regain compliance with Nasdaq Rule 5250(c)(1) by filing the Form 10-K with the SEC, which it expects to do as soon as practicable.

OMEX

Odyssey Marine Exploration Addresses NASDAQ Compliance Matters; Plans To Regain Compliance With Nasdaq Rule 5250(c)(1) By Filing The Form 10-K With The SEC, Which It Expects To Do As Soon As Practicable

These Consumer Cyclical stocks are trading higher:-Ranpak Holdings Corp (PACK) stock is trading at $6.41, a rise of $2.04, or 46.68%, on high volume.  Ranpak Holdings Corp gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $6.33.  -AT

Consumer Cyclical Stocks Making Moves Tuesday: PACK, RERE, JZXN, BZUN, GOEV, ONON, AEVA, VRM

ATRenew Inc (RERE) is down -7.28%% today. RERE has an Overall Score of 14. Find out what this means to you and get the rest of the rankings on RERE!See Full RERE ReportRERE stock closed at $1.51 and is down -$0.11 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most inve

ATRenew Inc (RERE) is lower by 7.28% Wednesday In Premarket Trading

ATRenew Reported Excellent 2023 Results But The Stock Is Undervalued

ATRenew Inc (RERE) has fallen Thursday morning, with the stock losing -2.52% in pre-market trading to 1.55. RERE's short-term technical score of 11 indicates that the stock has traded less bullishly over the last month than 89% of stocks on the market. In the Internet Retail industry, which ranks 116 out of 146 industries,

Should You Buy ATRenew Inc (RERE) Stock Thursday Morning?

China Government Promotes Green Economy, And ATRenew Stands Out As A Main Enabler

ATRenew Inc (RERE) stock is down -33.46% over the last 12 months. InvestorsObserverâ€&#x2122;s proprietary ranking system, gives RERE stock a score of  14 out of a possible 100. That rank is chiefly influenced by a short-term technical score of 14. RERE's rank also includes a long-term technical score of 27.  RERE has an Overall Sc

Is ATRenew Inc (RERE) Stock a Smart Investment Monday?

Bank of America Securities analyst Joyce Ju maintained a Buy rating on ATRenew Inc. Sponsored ADR (RERE – Research Report) today. The company's sha...

Bank of America Securities Keeps Their Buy Rating on ATRenew Inc. Sponsored ADR (RERE)

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
As investors, we all aim to outperform the market. But beating the S&amp;P 500 is a difficult task for most of us. Outperforming the Nasdaq Index has proven to be an even greater challenge in recent years. That&rsquo;s because this tech-heavy index has been on a tear over the past two decades, buoyed by high-growth companies generating some impressive returns. However, most of the Nasdaq&rsquo;s meteoric rise has come from just a handful of stellar <a href="https://investorplace.com/stock-types/growth-stocks/">growth stocks</a>.



By identifying and investing in such quality growth stocks for the long-haul, you stand a good chance of earning higher returns than the Nasdaq. Great businesses rarely disappoint when given enough time, and many of the companies on this list have decades of growth behind them to propel their future ascent.



Thus, it pays to focus on quality. As legendary investor Philip Fisher said, &ldquo;The stock market is filled with individuals who know the price of everything, but the value of nothing.&rdquo; By buying great growth companies at reasonable valuations, holding them for the long-term, and allowing their earnings growth to compound over time, you stand a good chance of beating the Nasdaq. 



Let&rsquo;s take a look at the top growth stocks I think are worth buying right now!



<h2>MercadoLibre (MELI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/08/meli1600-300x169.jpg" alt="MercadoLibre (MELI) homepage on a smartphone"><div>Source: rafapress / Shutterstock.com</div></div>MercadoLibre (NASDAQ:<a href="https://investorplace.com/stock-quotes/meli-stock-quote/">MELI</a>) is quickly becoming the Amazon (NASDAQ:<a href="https://investorplace.com/stock-quotes/amzn-stock-quote/">AMZN</a>) of Latin America, if it isn&rsquo;t already. That&rsquo;s one of the key reasons I remain bullish on MercadoLibre for the long-run. 



This company has immense potential given the still underpenetrated e-commerce and digital payments markets across Latin America. As internet access and smartphone penetration continue improving across the region, MercadoLibre stands to benefit. Its e-commerce platform is already the dominant option in this region, and its Mercado Pago digital payments system is gaining tremendous traction as well.



Recent growth estimates illustrate the vast runway ahead. MercadoLibre is expected to expand margins rapidly this decade, with <a href="https://seekingalpha.com/symbol/MELI/earnings/estimates">earnings per share expected to climb from $33 in 2024 to $226 in 2033</a>. This is alongside revenue climbing from $18 billion to $72 billion over the same timeframe. If Latin American economies grow better than expected, we could see even higher growth.



Specifically, I&rsquo;m keeping an eye on Argentina&rsquo;s potential over the next decade. If President Javier Milei&rsquo;s free-market economic reforms manage to unleash growth in the country, MercadoLibre stands to be a major beneficiary. While risks certainly exist, the company&rsquo;s upside potential is too significant to ignore.



Moreover, the stock itself has pulled back a little from the $1,800 range to the $1,500 range recently. This looks like a solid buying opportunity for long-term investors. MercadoLibre still trades at a premium valuation, but remains one of the top growth stocks to own for emerging market exposure over the next decade.



<h2>FTAI Aviation (FTAI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/12/jets-airlines-airport-1600-300x169.jpg" alt="a close-up shot of an airplane engine"><div>Source: frank_peters / Shutterstock.com</div></div>This is one of the growth stocks I have written about quite a lot recently, and it is hard to ignore such a quality business. The private aviation industry has seen a lot of growth, especially after Trump&rsquo;s tax cuts made it possible for people to write off private jet expenses as business expenses. FTAI Aviation (NASDAQ:<a href="https://investorplace.com/stock-quotes/ftai-stock-quote/">FTAI</a>) specializes in CFM56 engines, which are used a lot more by commercial planes, but also in the commercial aviation sector as well.



While risks exist in the near-term, I remain bullish on FTAI stock over the long run due to the company&rsquo;s dominant market position and the aforementioned secular tailwinds for private aviation. FTAI owns and leases commercial aircraft engines, with a specialty in CFM56 engines used widely by airliners and private jet operators. With brisk air travel demand globally, FTAI is well-positioned to capitalize on the growing demand for engines and maintenance services.



Notably, FTAI stock is up 144% in the past year, and while I think it could have a correction in the near-term, the long-term upside potential with this stock seems solid. FTAI is <a href="https://seekingalpha.com/symbol/FTAI/earnings/estimates">expected to grow its earnings from $2 per share in 2024 to $6 per share in 2027</a>. Paying 34-times forward earnings for that sort of growth is still cheap in my view for this kind of quality business.



The company&rsquo;s margins are also very impressive already. FTAI&rsquo;s <a href="https://www.google.com/finance/quote/FTAI:NASDAQ">net margin of 38% in Q4</a> is easily better than 95%-plus business services companies. That net margin was 21% for all of 2023, so I think continued margin expansion can continue.



As a sweetener, FTAI also provides a dividend yield of 1.8% currently. The payout is still low relative to the company&rsquo;s earnings, so dividend growth should be robust over the coming years.



<h2>Gambling.com (GAMB)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/11/dice-chance-gamble-1600-300x169.jpg" alt="A photo of 2 red dice rolling on a black mirrored background."><div>Source: 7th Sun / Shutterstock.com</div></div>Gambling.com (NASDAQ:<a href="https://investorplace.com/stock-quotes/gamb-stock-quote/">GAMB</a>) does exactly as the name suggests. The company&rsquo;s focus is on online casinos, online sports betting, and the fantasy sports industry. The company also engages in digital marketing for other gambling and sports betting companies. These sorts of companies have been doing very well recently as sports betting explodes in popularity.



I&rsquo;m bullish on Gambling.com due to the immense growth in online sports betting and gambling across the U.S., with more states legalizing online betting. It&rsquo;s estimated that roughly 39% of Americans bet on sports, and 15% say they know someone with a related gambling problem. Over 80 percent of American adults gamble on a yearly basis. This is a huge market, and it is opening up even more due to strong lobbying by gambling companies across the U.S.



These tailwinds explain why Gambling.com has been executing so well lately. It has a 3-year average <a href="https://www.gurufocus.com/stock/GAMB/summary">annual revenue growth rate of over 50%</a>, which is better than 93% of its industry peers. I expect the robust growth to continue. Gambling.com is looking at <a href="https://seekingalpha.com/symbol/GAMB/earnings/estimates">revenue increasing from $131 million in 2024 to $197 million</a> in 2027, per analyst estimates.



While analysts agree that the company&rsquo;s earnings growth outlook is more muted, I believe the potential is there for significant bottom-line expansion as well if the company can continue gaining share in this booming industry.



<h2>ATRenew (RERE)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/01/tech-stocks1600-300x169.png" alt="Business man using computer hand close up futuristic cyber space decentralized finance coding background, business data analytics programming online VPN network metaverse digital world technology. tech stocks"><div>Source: thinkhubstudio / Shutterstock.com</div></div>ATRenew (NYSE:<a href="https://investorplace.com/stock-quotes/rere-stock-quote/">RERE</a>) operates a leading technology-driven pre-owned consumer electronics transactions and services platform in China under the brand ATRenew. This firm primarily sells mobile phones, laptops, tablets, drones, digital cameras, household products, and bags through online platforms and offline stores.



I remain optimistic about ATRenew, despite the broader challenges facing the Chinese economy. Growth has slowed in China after the pandemic recovery, especially for tech companies dealing with deflation and soft consumer spending. However, I believe Chinese companies could be poised for a resurgence as the country&rsquo;s monetary policy stance becomes more accommodative.



ATRenew itself looks attractively valued here. It <a href="https://seekingalpha.com/symbol/RERE/earnings/estimates">trades at just 5-times forward earnings</a> currently, which seems far too cheap given the company&rsquo;s growth profile. ATRenew is expected to grow earnings by 90% in 2024 and another 54% in 2025, with revenue growth above 25% per year. This type of rapid growth typically warrants a much higher multiple.



The company&rsquo;s balance sheet also appears healthy, with $337 million in cash against only $52 million of debt. There are no glaring financial risks that stand out.



Given the stock&rsquo;s rock-bottom valuation and impressive growth metrics, I see significant upside potential in ATRenew. The company is executing well despite broader economic headwinds in China. As macro conditions eventually improve, ATRenew looks poised to reward investors handsomely.



<h2>Opthea (OPT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/02/medical-biotech-stocks1600-300x169.png" alt="Healthcare business graph data and growth, Medical examination and doctor analyzing medical report network connection on tablet screen. VANI stock"><div>Source: PopTika / Shutterstock.com</div></div>Opthea (NASDAQ:<a href="https://investorplace.com/stock-quotes/opt-stock-quote/">OPT</a>) is a more high-risk, high-reward biotech bet to consider, since the company has not generated revenue yet. It is a clinical-stage biopharmaceutical company dedicated to developing and commercializing therapies primarily for eye diseases. Opthea&rsquo;s focus lies in addressing the unmet needs of patients with highly-prevalent and progressive retinal conditions, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME).



I don&rsquo;t often discuss <a href="https://investorplace.com/industries/healthcare/biotech/">biotech stocks</a>, but Opthea intrigues me as a potential high-growth opportunity if its drug development goes as planned. The company is based in Australia, and focuses on the large global market for retinal disease treatments.



According to estimates, if Opthea delivers on expectations, the stock could trade around just <a href="https://seekingalpha.com/symbol/OPT/earnings/estimates">2.6-times 2028 earnings</a>. Sales could potentially soar from $5.7 million in 2024 to $2.4 billion in 2033 if its pipeline successfully materializes. While clinical failures always pose a risk, the upside scenario for this stock makes this a worthwhile speculative bet.



With $157 million in cash, Opthea also has a decent runway to continue funding its research and development until profitability is achieved. The risk-reward profile looks favorable for investors willing to take on some volatility with this name.



<h2>Li Auto (LI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/01/li1600-2-300x169.png" alt="The steering wheel and dashboard inside Li Auto electric car. Interior of Li Auto EV. Li Auto Also known as Li Xiang, is a Chinese electric vehicle company"><div>Source: Robert Way / Shutterstock.com</div></div>Li Auto (NASDAQ:<a href="https://investorplace.com/stock-quotes/li-stock-quote/">LI</a>) has been an outstanding electric vehicle startup in my view. As I&rsquo;ve noted many times before, most EV startups have been bleeding cash at an alarming rate. Li Auto stands out as a rare profitable EV maker with stellar top-line growth.



Now, LI stock did recently stumble after the company <a href="https://nz.finance.yahoo.com/news/li-auto-li-revises-guidance-140500766.html">cut its Q1 delivery guidance by 24%</a>. However, even with this lower forecast, Li Auto will likely beat expectations. In March alone, the company <a href="https://ir.lixiang.com/news-releases/news-release-details/li-auto-inc-march-2024-delivery-update">delivered 28,984 vehicles, up 39.2% year-over-year</a>. This recent slower pace of deliveries resulted from inventory shortages during the Chinese New Year. For the full first quarter, Li Auto still projects rapid growth, relative to any other automaker.



Despite strong operational metrics, LI stock trades at just 16-times forward earnings and 1.1-times forward sales. That seems remarkably inexpensive compared to money-losing EV startups with questionable outlooks.



In my view, the company&rsquo;s recent guidance cut appears to be just a temporary speed bump. With brisk demand in China, Li Auto looks poised to continue gaining market share and rewarding shareholders.



<h2>D-Market (HEPS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/01/shutterstock_1136020895-300x169.png" alt="Turkish flag with city in background"><div>Source: Halil ibrahim SARI / Shutterstock.com</div></div>D-Market (NASDAQ:<a href="https://investorplace.com/stock-quotes/heps-stock-quote/">HEPS</a>) is a Turkish e-commerce company that has been trading sideways around $1-$2 per share for nearly two years now. However, I think there is a strong possibility of a breakout as the company&rsquo;s financial performance improves.



Admittedly, Turkey&rsquo;s shaky macroeconomic situation does warrant caution with this name. Turkey has struggled to get inflation under control even with aggressive rate hikes, and inflation remains elevated.



However, even with high interest rates and inflation headwinds, D-Market is expected to grow at a brisk pace. The company&rsquo;s earnings are <a href="http://seekingalpha.com/symbol/HEPS/earnings/estimates">projected to more than double from 3 cents to 7 cents</a>, along with around 30% annual revenue growth. This kind of growth trajectory typically warrants a much higher valuation.



If Turkey can eventually get inflation trending lower and stabilize its economy, D-Market could potentially generate multi-bagger returns from current levels. The company&rsquo;s growth outlook remains healthy, despite the challenging operating environment. While not without risks, I believe D-Market has breakout potential if the company&rsquo;s management team continues to execute well. 



On the date of publication, Omor Ibne Ehsan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a>
<div>Omor Ibne Ehsan is a writer at InvestorPlace. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks. You can follow him on <a href="https://www.linkedin.com/in/omor-ibne-ehsan-56068022b/">LinkedIn</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/7-growth-stocks-to-buy-to-outperform-the-nasdaq-index/">7 Growth Stocks to Buy to Outperform the Nasdaq Index</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Growth Stocks to Buy to Outperform the Nasdaq Index

The internet industry thrives thanks to expanding usage, its transformative impact on work and communication globally, advancements in 5G, and its widespread integration into daily life. Hence, it could be wise to consider adding internet stocks ATRenew (RERE), Chegg (CHGG), and 1-800-FLOWERS.COM (FLWS) to one's portfolio for growth. Read on... The internet's demand arises from its pivotal role in digitizing sectors, enhancing digital services, and improving global user experiences. High-speed internet connectivity has revolutionized e-commerce globally, transformed education with online learning, enabled remote work through virtual collaboration, and reshaped media consumption, positioning the internet industry for solid long-term growth.
Given this backdrop, investors could consider buying fundamentally strong internet stocks ATRenew Inc. (<a href="https://stocknews.com/stock/RERE/">RERE</a>), Chegg, Inc. (<a href="https://stocknews.com/stock/CHGG/">CHGG</a>), and 1-800-FLOWERS.COM, Inc. (<a href="https://stocknews.com/stock/FLWS/">FLWS</a>), given their solid growth prospects.
As of 2023, global internet users reached 5.4 billion, up from 5.3 billion, <a href="https://www.statista.com/statistics/273018/number-of-internet-users-worldwide/">constituting 67%</a> of the world's population. Enhanced computer access, innovations in virtual reality (VR) and augmented reality (AR), and increased smartphone use have boosted internet usage, benefiting the industry. The global internet services market is projected to grow at a <a href="https://www.businessresearchinsights.com/market-reports/internet-service-market-104518">4.4% CAGR</a>, reaching $733.79 billion by 2031
The advent of 5G, with faster speeds and network density, fuels innovation and economic growth and improves user experiences, benefiting e-commerce and EdTech platforms. The global 5G services market is projected to grow at a <a href="https://www.grandviewresearch.com/industry-analysis/5g-services-market">59.4% CAGR</a> from 2023 to 2030, reaching $2.21 trillion by 2030.
Furthermore, Investors' interest in Internet stocks is evident from the Invesco NASDAQ Internet ETF's (<a href="https://stocknews.com/stock/PNQI/">PNQI</a>) 37.5% returns over the past year.
Considering these conducive trends, let's examine the fundamentals of the three <a href="https://stocknews.com/category/internet/">Internet</a> stock picks mentioned above, beginning with the third choice.
Stock #3: ATRenew Inc. (<a href="https://stocknews.com/stock/RERE/">RERE</a>)
Headquartered in Shanghai, the People's Republic of China, RERE and its subsidiaries operate a pre-owned consumer electronics transactions and services platform in the People's Republic of China.
RERE's revenue grew at a CAGR of 38.7% over the past three years. Likewise, its Total Assets grew at a CAGR of 1.7% over the past three years.
In terms of forward EV/Sales, RERE's 0.03x is 97.6% lower than the 1.16x industry average. Its 1.58x forward <a href="https://www.investopedia.com/terms/e/ev-ebitda.asp">EV/EBITDA</a> is 82.8% lower than the 9.16x industry average. Likewise, its 1.07x forward EV/EBIT is 91.9% lower than the 13.16x industry average.
For the fiscal fourth quarter that ended December 31, 2023, RERE's net product revenues and net service revenues increased 31% and 19.7% year-over-year to RMB2.69 billion ($371.53 million) and RMB293.26 million ($40.50 million), respectively. Its adjusted income from operations came in at RMB81.58 million ($11.27 million).
For the same quarter, the company's adjusted net income grew 305.2% over the prior-year quarter to RMB91.02 million ($12.57 million). In addition, its adjusted net income per ordinary share stood at RMB0.57, up 338.5% year-over-year.
Street expects RERE's EPS and revenue for the quarter ended March 31, 2024, to increase 75.7% and 25.8% year-over-year to $0.07 and $512.07 million, respectively. Over the past three months, the stock has gained 22.8% to close the last trading session at $1.56.
RERE's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect its strong fundamentals. It has an overall rating of B, equating to a Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.
It has a B grade for Growth, Value, and Sentiment. Within the B-rated <a href="https://stocknews.com/category/internet/">Internet</a> industry, it is ranked #19 out of 54 stocks. To see RERE's ratings for Momentum, Stability, and Quality, <a href="https://stocknews.com/stock/RERE/">click here</a>.
Stock #2: Chegg, Inc. (<a href="https://stocknews.com/stock/CHGG/">CHGG</a>)
CHGG operates a direct-to-student learning platform that helps learners build essential life and job skills to accelerate their path from learning programs internationally. Its subscription services include Chegg Study, Tinger Gold, DashPash Student services, Chegg Writing, Chegg Math, Chegg Study Pack, and Busuu.
CHGG's levered FCF grew at a CAGR of 16.6% over the past three years. Also, its revenue grew at a CAGR of 17.4% during the same period.
In terms of forward non-GAAP P/E, CHGG's 6.25x is 57.9% lower than the 14.85x industry average. Likewise, its 0.25x forward non-GAAP PEG is 82.6% lower than the 1.44x industry average. Furthermore, its 5.27x forward EV/EBITDA is 42.5% lower than the 9.16x industry average.
CHGG's net revenues for the fiscal fourth quarter that ended December 31, 2023, amounted to $187.99 million. The company's non-GAAP gross profit stood at $145.87 million. Its non-GAAP net income and net income per share came in at $42.66 million and $0.36, respectively.
Moreover, as of December 31, 2023, the company's total liabilities stood at $782.62 million, compared to $1.35 billion as of December 31, 2022.
For the quarter ending September 30, 2024, CHGG's EPS is expected to increase 9.3% year-over-year to $0.20. Its revenue for fiscal 2025 is expected to increase 1.5% year-over-year to $695.82 million. Over the past month, CHGG's stock has declined 10.2% to close the last trading session at $7.03.
CHGG's bright prospects are reflected in its POWR Ratings. It has an overall rating of B, equating to a Buy in our proprietary rating system.
It has an A grade for Value and a B for Growth and Quality. It is ranked #11 in the same industry. To access the additional grades of CHGG for Momentum, Stability, and Sentiment, <a href="https://stocknews.com/stock/CHGG/">click here</a>.
Stock #1: 1-800-FLOWERS.COM, Inc. (<a href="https://stocknews.com/stock/FLWS/">FLWS</a>)
FLWS provides gifts for various occasions internationally. It operates through three segments: Consumer Floral &amp; Gifts, Gourmet Foods &amp; Gift Baskets, and BloomNet.
On January 25, 2024, Cheryl's Cookies, a FLWS brand, announced its strategic expansion into the ice cream market, offering gourmet ice cream flavors inspired by their popular cookie flavors. They also introduced a Cookie &amp; Ice Cream Sandwich Making Kit for customers to enjoy personalized dessert adventures at home.
FLWS' revenue grew at a CAGR of 9.5% over the past five years. Moreover, its Tang Book Value grew at a CAGR of 15.9% over the past three years.
In terms of forward EV/Sales, FLWS' 0.30x is 73.8% lower than the 1.16x industry average. Its 6.02x forward EV/EBITDA is 34.3% lower than the 9.16x industry average. Additionally, its 1.21x forward Price/Book is 46.2% lower than the 2.25x industry average.
For the fiscal second quarter that ended December 31, 2023, FLWS reported adjusted net revenues of $822.05 million. The company's adjusted net income stood at $82.67 million or $1.27 per common share, respectively. Also, as of December 31, 2023, its total assets amounted to $1.19 billion, compared to $1.05 billion as of July 2, 2023.
Analysts expect FLWS' revenue for the quarter ending September 30, 2024, to increase 1.4% year-over-year to $272.76 million. Its EPS for fiscal 2025 is expected to increase 150.8% year-over-year to $0.40. It surpassed the consensus EPS estimate in each of the trailing four quarters. Over the past six months, the stock has gained 16.2% to close the last trading session at $8.77.
It's no surprise that FLWS has an overall rating of B, which translates to a Buy in our proprietary rating system.
It has a B grade for Growth, Sentiment, and Quality. It is ranked #10 in the Internet industry. In total, we rate FLWS on eight different levels. Beyond what we have stated above, we also have given FLWS grades for Value, Momentum, and Stability. Get all the FLWS ratings <a href="https://stocknews.com/stock/FLWS/">here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
CHGG shares were trading at $7.23 per share on Friday morning, up $0.20 (+2.84%). Year-to-date, CHGG has declined -36.36%, versus a 5.19% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Abhishek Bhuyan</h2> <img src='https:/wp-content/uploads/2023/07/ABhuyan.jpg' style="float:left; padding:5px;width:125px;">Abhishek embarked on his professional journey as a financial journalist due to his keen interest in discerning the fundamental factors that influence the future performance of financial instruments.<a href="https://stocknews.com/authors/?author=abhishek-bhuyan">More...</a>The post <a href=https://stocknews.com/news/chgg-flws-rere-3-internet-stocks-poised-up-for-rapid-growth-in-april/>3 Internet Stocks Poised up for Rapid Growth in April</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Internet Stocks Poised up for Rapid Growth in April

AEVA

AMZN

BABA

BABAF

BAIDF

BIDU

BZUN

CHGG

FLWS

FTAI

GAMB

GOEV

HEPS

JDCMF

JZXN

MELI

ONON

PACK

Press Releases

Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now

Yunji Announces Appointment of New Independent Director

Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on January 23, 2024

ATRenew to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

ATRenew Announces US$20 Million Share Repurchase Program

Earnings

ATRenew Inc. Reports Unaudited Fourth Quarter and Full Year 2023 Financial Results

Opinion

Thinking about buying stock in BigBear.ai, Nukkleus, Singularity Future Technology, Regulus Therapeutics, or ATRenew?

ATRenew Inc. Files 2023 Annual Report on Form 20-F

Entertainment

Commodities

Bamboo Works Spotlights Potential for Smartphone Recycling in Expert Opinion from ATRenew Chairman Kerry Chen